Willing and Abel: Berkshire's New CEO Makes Huge Portfolio Changes in Q1
Berkshire Hathaway has a new top dog. Its appears that Greg Abel is barking loudly, upending much of the company’s huge investment portfolio.
Source link
Similar Posts
Ahead of Market: 10 things that will decide stock action on Thursday
Domestic headline equity indices ended lower on Wednesday as investors booked profits across sectors, ahead of key U.S. inflation data that could influence the size of a likely reduction in Federal Reserve interest rates next week. The Nifty 50 index fell 0.49% to 24,918, while the S&P BSE Sensex lost 0.49% to 81,523. Here’s how…
BofA acquires stakes in Angel One, Nuvama in Rs 500 crore block transactions
Bank of America (BofA) on Friday bought shares in Angel One and Nuvama Wealth Management via block deals. In the former case, BofA bought over 15.19 lakh shares worth Rs 348 crore through its French subsidiary BofA Securities Europe SA while in the latter case 2.59 lakh shares amounting to Rs 154 crore, were purchased….
3 Dividend Stocks to Double Up on Right Now
If you’re looking for solid dividend stocks, you’re going to want ones that offer growth potential and a steady stream of income. In that case, investors might want to double up on North West Company (TSX:NWC), Brookfield Infrastructure Partners (TSX:BIP.UN), and Dollarama (TSX:DOL). Each of these companies presents an excellent opportunity for long-term investors seeking…
RAC – Race Oncology Limited
21 December 2021 – Race Oncology Limited (“Race”) is pleased to announce that its Share Purchase Plan (SPP) has closed heavily oversubscribed with $43.9m received in applications from 2,340 shareholders. In line with the terms of the SPP, $29.7m will be accepted, with funds to be applied to Race’s “full case” funding scenario, as set…
GTK – Gentrack Group Limited
Market Announcement Gentrack Group Limited (NZX/ASX: GTK), a leading provider of software solutions for utilities and airports, today released its results for the half-year to 31 March 2023. Results Summary • Revenue: $84.3m – up 47.7% on H1’22 • EBITDA $16.0m – up $14.8m over H1’22 • Statutory NPAT: $7.9m profit v $5.8m loss in…
